{"id":"https://openalex.org/W7220845040","doi":"https://doi.org/10.1016/j.ijid.2026.109171","title":"Beyond oxygen requirement: rethinking patient selection for oral antiviral therapy to inform trial design in the omicron era","display_name":"Beyond oxygen requirement: rethinking patient selection for oral antiviral therapy to inform trial design in the omicron era","publication_year":2026,"publication_date":"2026-10-07","ids":{"openalex":"https://openalex.org/W7220845040","doi":"https://doi.org/10.1016/j.ijid.2026.109171","pmid":"https://pubmed.ncbi.nlm.nih.gov/42838261"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijid.2026.109171","doi":"https://doi.org/10.1016/j.ijid.2026.109171","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijid.2026.109171","pdf_url":"https://www.ijidonline.com/article/S1201-9712(26)00806-4/pdf","source":{"id":"https://openalex.org/S35071406","display_name":"International Journal of Infectious Diseases","issn_l":"1201-9712","issn":["1201-9712","1878-3511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.ijidonline.com/article/S1201-9712(26)00806-4/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089102659","display_name":"Benjamin Davido","orcid":"https://orcid.org/0000-0002-2859-8417","observed_orcids":["https://orcid.org/0000-0002-2859-8417"]},"institutions":[{"id":"https://openalex.org/I195731000","display_name":"Universit\u00e9 de Versailles Saint-Quentin-en-Yvelines","ror":"https://ror.org/03mkjjy25","country_code":"FR","type":"education","lineage":["https://openalex.org/I195731000","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210134648","display_name":"H\u00f4pital Raymond-Poincar\u00e9","ror":"https://ror.org/03pef0w96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210134648"]},{"id":"https://openalex.org/I4390039363","display_name":"Infection et inflammation","ror":"https://ror.org/021sh3243","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I195731000","https://openalex.org/I277688954","https://openalex.org/I4390039363"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Benjamin Davido","raw_affiliation_strings":["Maladies infectieuses, AP-HP H\u00f4pital Raymond Poincar\u00e9, Universit\u00e9 Paris-Saclay, Garches, France; UMR1173, Universit\u00e9 Versailles Saint-Quentin, Montigny-Le-Bretonneux, France. Electronic address: benjamin.davido@aphp.fr"],"raw_orcid":"https://orcid.org/0000-0002-2859-8417","affiliations":[{"raw_affiliation_string":"Maladies infectieuses, AP-HP H\u00f4pital Raymond Poincar\u00e9, Universit\u00e9 Paris-Saclay, Garches, France; UMR1173, Universit\u00e9 Versailles Saint-Quentin, Montigny-Le-Bretonneux, France. Electronic address: benjamin.davido@aphp.fr","institution_ids":["https://openalex.org/I195731000","https://openalex.org/I277688954","https://openalex.org/I4210097159","https://openalex.org/I4210134648","https://openalex.org/I4390039363"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5157874388","display_name":"P. Loubet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I4210104607","display_name":"Centre Hospitalier Universitaire de N\u00eemes","ror":"https://ror.org/0275ye937","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210104607"]},{"id":"https://openalex.org/I4387154649","display_name":"Bacterial Virulence and Chronic Infections","ror":"https://ror.org/044jxv425","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4387154649"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Paul Loubet","raw_affiliation_strings":["Virulence Bact\u00e9rienne et Infections Chroniques, INSERM U1047, Univ Montpellier, Service des Maladies Infectieuses et Tropicales, CHU N\u00eemes, N\u00eemes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virulence Bact\u00e9rienne et Infections Chroniques, INSERM U1047, Univ Montpellier, Service des Maladies Infectieuses et Tropicales, CHU N\u00eemes, N\u00eemes, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I19894307","https://openalex.org/I4210104607","https://openalex.org/I4387154649"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5089102659"],"corresponding_institution_ids":["https://openalex.org/I195731000","https://openalex.org/I277688954","https://openalex.org/I4210097159","https://openalex.org/I4210134648","https://openalex.org/I4390039363"],"apc_list":{"value":2900,"currency":"USD","value_usd":2900},"apc_paid":{"value":2900,"currency":"USD","value_usd":2900},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.75813323,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"173","issue":null,"first_page":"109171","last_page":"109171"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11243","display_name":"Respiratory viral infections research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9829999804496765},{"id":"https://openalex.org/keywords/oral-antiviral-therapy","display_name":"oral antiviral therapy","score":0.9330000281333923},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.781000018119812},{"id":"https://openalex.org/keywords/nirmatrelvir-ritonavir","display_name":"nirmatrelvir/ritonavir","score":0.9359999895095825},{"id":"https://openalex.org/keywords/omicron-sublineages","display_name":"Omicron subvariants","score":0.9350000023841858},{"id":"https://openalex.org/keywords/supplemental-oxygen-requirement","display_name":"supplemental oxygen requirement","score":0.8859999775886536},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.6449999809265137},{"id":"https://openalex.org/keywords/hybrid-immunity","display_name":"hybrid immunity","score":0.7549999952316284},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.8090000152587891},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.5740000009536743},{"id":"https://openalex.org/keywords/symptom-duration","display_name":"symptom duration","score":0.6050000190734863},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.671999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7591000199317932},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.722000002861023},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6779000163078308},{"id":"https://openalex.org/C2993512173","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral therapy","level":4,"score":0.6617000102996826},{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.5788999795913696},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.5648000240325928},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.4819999933242798},{"id":"https://openalex.org/C89623803","wikidata":"https://www.wikidata.org/wiki/Q12184","display_name":"Pandemic","level":5,"score":0.45989999175071716},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45329999923706055},{"id":"https://openalex.org/C2780385302","wikidata":"https://www.wikidata.org/wiki/Q367158","display_name":"Protocol (science)","level":3,"score":0.3871000111103058},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.38440001010894775},{"id":"https://openalex.org/C3006700255","wikidata":"https://www.wikidata.org/wiki/Q81068910","display_name":"2019-20 coronavirus outbreak","level":3,"score":0.35409998893737793},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.34119999408721924},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3206000030040741},{"id":"https://openalex.org/C2986302931","wikidata":"https://www.wikidata.org/wiki/Q764759","display_name":"Positive selection","level":3,"score":0.2980000078678131},{"id":"https://openalex.org/C3020505244","wikidata":"https://www.wikidata.org/wiki/Q846227","display_name":"Antiviral treatment","level":4,"score":0.27810001373291016}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ijid.2026.109171","doi":"https://doi.org/10.1016/j.ijid.2026.109171","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijid.2026.109171","pdf_url":"https://www.ijidonline.com/article/S1201-9712(26)00806-4/pdf","source":{"id":"https://openalex.org/S35071406","display_name":"International Journal of Infectious Diseases","issn_l":"1201-9712","issn":["1201-9712","1878-3511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:42838261","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42838261","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:4a3ddae28a944f608f8de9e339ba4f3b","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/4a3ddae28a944f608f8de9e339ba4f3b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Infectious Diseases, Vol 173, Iss , Pp 109171- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ijid.2026.109171","doi":"https://doi.org/10.1016/j.ijid.2026.109171","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijid.2026.109171","pdf_url":"https://www.ijidonline.com/article/S1201-9712(26)00806-4/pdf","source":{"id":"https://openalex.org/S35071406","display_name":"International Journal of Infectious Diseases","issn_l":"1201-9712","issn":["1201-9712","1878-3511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220845040.pdf","grobid_xml":"https://content.openalex.org/works/W7220845040.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W3042270788","https://openalex.org/W3216810195","https://openalex.org/W4212904481","https://openalex.org/W4306780101","https://openalex.org/W4315782555","https://openalex.org/W4384283521","https://openalex.org/W4385765515","https://openalex.org/W4387115805","https://openalex.org/W4390918915","https://openalex.org/W4391824355","https://openalex.org/W4394573255","https://openalex.org/W4399573274","https://openalex.org/W4404291373","https://openalex.org/W4410383600","https://openalex.org/W4412025636","https://openalex.org/W7147127129"],"related_works":["https://openalex.org/W4310817814","https://openalex.org/W4361980142","https://openalex.org/W4379375973","https://openalex.org/W4287009113","https://openalex.org/W7213364898","https://openalex.org/W4382995261","https://openalex.org/W4388583175","https://openalex.org/W4311732046","https://openalex.org/W4221117156","https://openalex.org/W4309604538"],"abstract_inverted_index":{"Current":[0],"COVID-19":[1,60,158],"therapeutic":[2,131],"recommendations":[3],"for":[4,40],"oral":[5,80,153],"antiviral":[6,81,126,154],"therapy":[7,155],"rely":[8],"on":[9,109],"a":[10,142],"stage-based":[11],"framework":[12],"established":[13],"during":[14],"the":[15,54,85,129,150],"first":[16],"pandemic":[17],"waves,":[18],"restricting":[19],"treatment":[20],"to":[21],"patients":[22,42],"presenting":[23],"within":[24,128],"five":[25],"days":[26],"of":[27,59,87,152],"symptom":[28,103],"onset":[29],"who":[30],"do":[31],"not":[32,123],"require":[33],"supplemental":[34,44],"oxygen,":[35],"whereas":[36],"corticosteroids":[37],"are":[38],"recommended":[39],"hospitalized":[41,75],"requiring":[43],"oxygen.":[45],"Although":[46],"this":[47,120],"strategy":[48,147],"remains":[49],"supported":[50],"by":[51,160],"randomized":[52],"evidence,":[53],"biological":[55],"and":[56,70,73,116],"clinical":[57,100],"landscape":[58],"has":[61],"profoundly":[62],"evolved":[63],"with":[64],"widespread":[65],"hybrid":[66],"immunity,":[67],"Omicron":[68,161],"sublineages,":[69],"an":[71,93,98],"older":[72],"immunocompromised":[74],"population.":[76],"We":[77],"propose":[78],"that":[79,136],"eligibility,":[82],"primarily":[83],"in":[84,156],"context":[86],"nirmatrelvir/ritonavir,":[88],"should":[89,139],"progressively":[90],"move":[91],"beyond":[92],"oxygen-centered":[94],"eligibility":[95],"algorithm":[96],"toward":[97],"integrated":[99,144],"assessment":[101],"including":[102],"duration,":[104],"host":[105],"characteristics,":[106],"pulmonary":[107],"involvement":[108],"chest":[110],"CT,":[111],"virological":[112],"burden":[113],"(when":[114],"available),":[115],"oxygen":[117],"requirement.":[118],"Importantly,":[119],"perspective":[121],"does":[122],"challenge":[124],"early":[125],"initiation":[127],"approved":[130],"window.":[132],"Rather,":[133],"it":[134],"argues":[135],"future":[137],"studies":[138],"determine":[140],"whether":[141],"more":[143],"patient":[145],"selection":[146],"can":[148],"optimize":[149],"use":[151],"contemporary":[157],"caused":[159],"sublineages.":[162]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2026-10-08T00:00:00"}